We are live on ! Find out more
CRBU icon

Caribou Biosciences

133 hedge funds and large institutions have $93.1M invested in Caribou Biosciences in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 27

36% more call options, than puts

Call options by funds: $240K | Put options by funds: $176K

23% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 22

6.39% more ownership

Funds ownership: 57.96%64.35% (+6.4%)

3% more funds holding

Funds holding: 129133 (+4)

10% less capital invested

Capital invested by funds: $103M → $93.1M (-$10M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
133
Holders Change
+4
Holders Change %
+3.1%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
27
Increased
48
Reduced
27
Closed
22
Calls
$240K
Puts
$176K
Net Calls
+$64K
Net Calls Change
-$114K
Name Holding Trade Value Shares
Change
Change in
Stake
MC
26
Maverick Capital
Texas
$1.04M
7IH
27
72 Investment Holdings
Connecticut
$754K
Ameriprise
28
Ameriprise
Minnesota
$649K +$821K +408,058 New
UBS Group
29
UBS Group
Switzerland
$630K +$481K +239,049 +152%
DekaBank Deutsche Girozentrale
30
DekaBank Deutsche Girozentrale
Germany
$630K
Jane Street
31
Jane Street
New York
$542K -$622K -309,120 -48%
N
32
Nuveen
North Carolina
$526K +$127K +63,096 +24%
BC
33
Bruce & Co
Illinois
$398K -$101K -50,000 -17%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$358K -$31.8K -15,809 -7%
BCM
35
Bridgeway Capital Management
Texas
$327K -$57.3K -28,501 -12%
Thrivent Financial for Lutherans
36
Thrivent Financial for Lutherans
Minnesota
$297K +$160K +79,636 +74%
Aberdeen Group
37
Aberdeen Group
United Kingdom
$289K
GAA
38
Green Alpha Advisors
Colorado
$288K +$157K +77,840 +75%
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
$288K +$364K +180,823 New
Mirae Asset Global ETFs Holdings
40
Mirae Asset Global ETFs Holdings
Hong Kong
$281K +$16.5K +8,199 +5%
AllianceBernstein
41
AllianceBernstein
Tennessee
$273K
MAM
42
Milestone Asset Management
Pennsylvania
$260K +$17.4K +8,662 +6%
American Century Companies
43
American Century Companies
Missouri
$254K +$27K +13,421 +9%
Barclays
44
Barclays
United Kingdom
$231K +$31.3K +15,578 +12%
Verition Fund Management
45
Verition Fund Management
Connecticut
$223K +$282K +140,101 New
Ohio Public Employees Retirement System (OPERS)
46
Ohio Public Employees Retirement System (OPERS)
Ohio
$222K +$280K +139,486 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$204K +$3.09K +1,535 +1%
WP
48
Woodline Partners
California
$194K
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$188K +$238K +118,265 New
SL
50
Siren LLC
Connecticut
$168K

CRBU Hedge Fund Activity: Q4 2024 in Review

133 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q4 2024, worth a combined $93.1M — down 9.7% from $103M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new CRBU positions and 22 closed out — a net gain of 5 holders — while 48 added to existing stakes and 27 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $4.15M. The largest seller was Bank of America, cutting an estimated $5.63M.

  • 133 institutional investors held Caribou Biosciences (CRBU) as of Q4 2024, up from 129 in Q3 2024.
  • Funds reported $93.1M of Caribou Biosciences stock for Q4 2024, down 9.7% quarter-over-quarter.
  • 27 funds opened new Caribou Biosciences positions in Q4 2024 and 22 closed out, a net change of +5 holders.
  • The largest Caribou Biosciences buyer in Q4 2024 was JP Morgan Chase, an estimated $4.15M added.
  • The largest Caribou Biosciences seller in Q4 2024 was Bank of America, an estimated $5.63M sold.

Based on aggregated 13F filings for Q4 2024.